Blade Therapeutics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Blade Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011875
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Blade Therapeutics Inc (Blade Therapeutics) is a biopharmaceutical company which develops novel anti-fibrotic therapies to treat various fibrotic disorders. Its lead program is a small molecule inhibitor targeting an intracellular cysteine protease associated with fibrosis across diverse indications. Blade conducts research and development programs to discover new drugs that modulate fibrosis-related diseases such as diabetic nephropathy (DN), idiopathic pulmonary fibrosis (IPF), non-alcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC), systemic sclerosis (SSc), and corneal fibrosis. The company works in partnership with Scleroderma Research Foundation (SRF) to treat disorders of fibrosis, including scleroderma. Blade Therapeutics is headquartered in South San Francisco, California, the US.

Blade Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Blade Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Blade Therapeutics Raises Additional USD18.3 Million in Series B Financing 10
Blade Therapeutics Raises USD27 Million in Series B Financing 12
Blade Therapeutics Raises USD6.5 Million in Series A Financing 14
Blade Therapeutics Raises Funds in Venture Financing 15
Licensing Agreements 16
Blade Therapeutics Enters into Licensing Agreement with Johns Hopkins University School of Medicine 16
Blade Therapeutics Inc – Key Competitors 17
Blade Therapeutics Inc – Key Employees 18
Blade Therapeutics Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
Jun 20, 2017: Blade Therapeutics Expands Leadership Team as Company Advances R&D Pipeline Addressing Fibrotic Diseases 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Blade Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Blade Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Blade Therapeutics Raises Additional USD18.3 Million in Series B Financing 10
Blade Therapeutics Raises USD27 Million in Series B Financing 12
Blade Therapeutics Raises USD6.5 Million in Series A Financing 14
Blade Therapeutics Raises Funds in Venture Financing 15
Blade Therapeutics Enters into Licensing Agreement with Johns Hopkins University School of Medicine 16
Blade Therapeutics Inc, Key Competitors 17
Blade Therapeutics Inc, Key Employees 18

★海外企業調査レポート[Blade Therapeutics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Delta Air Lines, Inc.:企業のM&A・事業提携・投資動向
    Delta Air Lines, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Delta Air Lines, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • UnitedHealth Group Inc (UNH):製薬・医療:M&Aディール及び事業提携情報
    Summary UnitedHealth Group Inc (UnitedHealth Group) is a diversified health care company. It offers health care services and products through two distinct platforms, namely UnitedHealthcare and Optum. Its UnitedHealthcare platform provides health care coverage and benefit services; and Optum platfor …
  • NeuroGenetic Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NeuroGenetic Pharmaceuticals Inc (NeuroGenetic Pharmaceuticals) is a pharmaceutical company that develops drugs for Alzheimer’s diseases. The company develops products with its gamma-secretase modulators technology. It applies multiple lead compounds for the treatment of neurodegenerative co …
  • Bio-Rad Laboratories, Inc.:戦略・SWOT・企業財務分析
    Bio-Rad Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bio-Rad Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • North Eastern Electric Power Corporation Ltd:企業の戦略的SWOT分析
    North Eastern Electric Power Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Australian Postal Corporation:戦略・SWOT・企業財務分析
    Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report Summary Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Anthem Inc (ANTM):企業の財務・戦略的SWOT分析
    Anthem Inc (ANTM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • The Hain Celestial Group, Inc.:戦略・SWOT・企業財務分析
    The Hain Celestial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Hain Celestial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Midas Group Ltd:企業の戦略・SWOT・財務情報
    Midas Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Midas Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Svenska Cellulosa Aktiebolaget:企業の戦略・SWOT・財務情報
    Svenska Cellulosa Aktiebolaget - Strategy, SWOT and Corporate Finance Report Summary Svenska Cellulosa Aktiebolaget - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Credit Du Nord Sa
    Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report Summary Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ana Holdings Inc.:戦略・SWOT・企業財務分析
    Ana Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Ana Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Keio Corporation (9008):企業の財務・戦略的SWOT分析
    Keio Corporation (9008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Agfa-Gevaert N.V. (AGFB):企業の財務・戦略的SWOT分析
    Agfa-Gevaert N.V. (AGFB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Seminole Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Seminole Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • New York Independent System Operator Inc:企業の戦略的SWOT分析
    New York Independent System Operator Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • PromptCare Inc-医療機器分野:企業M&A・提携分析
    Summary PromptCare Inc (PromptCare) is a healthcare center that respiratory products and home infusion services. The center provides respiratory services such as clinical support programs, patient-focused technology and testimonials. It provides home infusion therapies for patients of all ages with …
  • Intertape Polymer Group Inc (ITP):企業の財務・戦略的SWOT分析
    Intertape Polymer Group Inc (ITP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Dako AS-医療機器分野:企業M&A・提携分析
    Summary Dako A/S (Dako Denmark), a subsidiary of Agilent Technologies Inc is a diagnostic company. The company’s products include diagnostic antibodies, reagents and kits, software related products, instruments and related products, clone products, and synonym products. It also provides immunohistoc …
  • Camden Property Trust:企業の戦略・SWOT・財務情報
    Camden Property Trust - Strategy, SWOT and Corporate Finance Report Summary Camden Property Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆